Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07304089 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 37 to 38
    • Eligibility criteria expanded, about 9 words
    • Study description revised
  2. Study sites revised (37)v8
  3. Site details revised at 7 of 37 sitesv7
  4. Site details revised at 1 of 37 sitesv6
  5. Site details revised at 1 of 37 sitesv5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 36 to 37v4
  2. Study sites: 9 to 36v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2026 to Feb 5, 2026
    • Site details revised at 9 of 9 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia. The main objectives of this clinical trial are to determine the following: * Does VIM0423 therapy improve dystonia symptoms compared to placebo? * Is VIM0423 well tolerated in individuals with isolated dystonia? and * Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?
Trial Details
NCT Number NCT07304089
Lead Sponsor Vima Therapeutics
Conditions
(from sponsor)		 Dystonia
Related terms Dystonia, Dystonic Disorders, Torticollis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov